Partial blockade of nicotinic acetylcholine receptors improves the counterregulatory response to hypoglycemia in recurrently hypoglycemic rats

Am J Physiol Endocrinol Metab. 2014 Oct 1;307(7):E580-8. doi: 10.1152/ajpendo.00237.2014. Epub 2014 Aug 12.

Abstract

Recurrent exposure to hypoglycemia can impair the normal counterregulatory hormonal responses that guard against hypoglycemia, leading to hypoglycemia unawareness. This pathological condition known as hypoglycemia-associated autonomic failure (HAAF) is the main adverse consequence that prevents individuals with type 1 diabetes mellitus from attaining the long-term health benefits of tight glycemic control. The underlying molecular mechanisms responsible for the progressive loss of the epinephrine response to subsequent bouts of hypoglycemia, a hallmark sign of HAAF, are largely unknown. Normally, hypoglycemia triggers both the release and biosynthesis of epinephrine through activation of nicotinic acetylcholine receptors (nAChR) on the adrenal glands. We hypothesize that excessive cholinergic stimulation may contribute to impaired counterregulation. Here, we tested whether administration of the nAChR partial agonist cytisine to reduce postganglionic synaptic activity can preserve the counterregulatory hormone responses in an animal model of HAAF. Compared with nicotine, cytisine has limited efficacy to activate nAChRs and stimulate epinephrine release and synthesis. We evaluated adrenal catecholamine production and secretion in nondiabetic rats subjected to two daily episodes of hypoglycemia for 3 days, followed by a hyperinsulinemic hypoglycemic clamp on day 4. Recurrent hypoglycemia decreased epinephrine responses, and this was associated with suppressed TH mRNA induction (a measure of adrenal catecholamine synthetic capacity). Treatment with cytisine improved glucagon responses as well as epinephrine release and production in recurrently hypoglycemic animals. These data suggest that pharmacological manipulation of ganglionic nAChRs may be promising as a translational adjunctive therapy to avoid HAAF in type 1 diabetes mellitus.

Keywords: cytisine; epinephrine release; hypoglycemia-associated autonomic failure; partial nicotinic acetylcholine receptor agonists; tyrosine hydroxylase.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Glands / drug effects*
  • Adrenal Glands / metabolism
  • Alkaloids / pharmacology*
  • Animals
  • Autonomic Nervous System / drug effects*
  • Autonomic Nervous System / metabolism
  • Azocines / pharmacology
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Disease Models, Animal
  • Epinephrine / biosynthesis
  • Epinephrine / metabolism*
  • Gene Expression Profiling
  • Glucose Clamp Technique
  • Hypoglycemia / metabolism*
  • Male
  • Nicotinic Antagonists / pharmacology*
  • Quinolizines / pharmacology
  • RNA, Messenger
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Nicotinic*
  • Recurrence
  • Tyrosine 3-Monooxygenase / drug effects*
  • Tyrosine 3-Monooxygenase / genetics
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Alkaloids
  • Azocines
  • Blood Glucose
  • Nicotinic Antagonists
  • Quinolizines
  • RNA, Messenger
  • Receptors, Nicotinic
  • cytisine
  • Tyrosine 3-Monooxygenase
  • Epinephrine